Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
180.4 USD | +0.65% | +2.31% | +16.38% |
Mar. 27 | Barclays Raises AbbVie Price Target to $195 From $185, Maintains Overweight Rating | MT |
Mar. 25 | Deals of the day-Mergers and acquisitions | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.38% | 319B | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+2.62% | 210B | |
+1.64% | 210B | |
-6.54% | 201B | |
-3.51% | 157B | |
-0.60% | 153B |
- Stock
- Equities
- Stock AbbVie Inc. - Nyse
- News AbbVie Inc.
- AbbVie : Reports Encouraging Data From Phase 2 Study of Imbruvica/Venclexta Combination